Anxiety disorders affect roughly 10 to 15% of adults over 65 and are among the most common psychiatric conditions in older adults, often more common than depression in this age group. Presentation tends to be more physical and more focused on health concerns than in younger adults. Treatment considerations differ meaningfully: benzodiazepines are generally avoided because of fall and cognitive risks, SSRI selection requires attention to interactions and side effects (hyponatremia, bleeding risk), and the line between anxiety and early cognitive change can require careful evaluation.
Anxiety in older adults is under-recognized and undertreated. It's often dismissed as a normal part of aging, it isn't, or attributed to medical illness when it has an independent course. The clinical picture differs in ways that matter for both diagnosis and treatment.
Why it's often missed
Several factors converge.
Presentation differences. Older adults are less likely to verbalize psychological worry directly and more likely to present with physical symptoms: chest pain, shortness of breath, dizziness, sleep disruption, GI symptoms. These often lead to medical workups that come back unremarkable, leaving the underlying anxiety unrecognized.
Health concerns are often realistic. A 75-year-old worrying about her heart, her balance, her memory, or her surviving spouse is worrying about things that are statistically relevant. The line between proportionate concern and clinical anxiety is harder to draw than in younger adults.
Generational reluctance. Many older adults grew up in cultures and eras that didn't discuss mental health openly. The vocabulary for psychological experience may not be familiar or comfortable.
Healthcare focus. Medicare visits with primary care physicians are typically short and focus on medical issues. Mental health screening in geriatric primary care is improving but remains inconsistent.
Symptom overlap with medical conditions. Hyperthyroidism, cardiac arrhythmias, COPD, and several other conditions produce symptoms that look like anxiety. Distinguishing them requires a thorough medical evaluation.
What late-life anxiety looks like
Common presentations clinicians see in older adults:
Generalized worry that has been present for years but is becoming harder to manage. Often a chronic generalized anxiety pattern from earlier life that's destabilized by retirement, medical events, loss of a spouse, or cognitive changes.
New-onset anxiety in late life. Worth thinking about carefully. New psychiatric symptoms after age 65 deserve evaluation for underlying medical causes (thyroid disease, cardiac conditions, medication side effects, early cognitive disease) before being attributed to a primary anxiety disorder.
Anxiety about health. Worry about specific symptoms, frequent doctor visits, repeated checking of vital signs at home. This pattern can be a primary anxiety presentation or a manifestation of the underlying medical condition the person is worried about.
Anxiety about cognitive change. Worry about dementia is increasingly common. Some patients with subjective cognitive complaints turn out to have anxiety driving the perception of memory problems; others have early cognitive disease producing real symptoms that are being amplified by anxiety; a thorough evaluation can usually distinguish them.
Anxiety about falling, going out, being alone. A common late-life pattern, sometimes following a fall or medical event. Without intervention, this often progresses to substantial withdrawal from activities and social contact.
The cognitive evaluation question
One of the most important clinical questions in geriatric anxiety: does this patient have anxiety, early dementia, both, or anxiety mimicking cognitive disease? The answers matter for treatment and prognosis.
A few principles. Anxiety can produce subjective cognitive complaints (forgetting names, losing items, difficulty concentrating) that on formal neuropsychological testing look largely intact. Early dementia produces measurable cognitive change with anxiety often appearing as a secondary feature. Both can coexist, and treating the anxiety often clarifies what's going on cognitively.
The MoCA (Montreal Cognitive Assessment) and the MMSE (Mini-Mental State Examination) are common screening tools used in primary care. More comprehensive neuropsychological testing is available through neuropsychologists when the clinical question is complex.
Medication considerations
The medication picture differs from younger adult anxiety treatment in several important ways.
Benzodiazepines are generally avoided. Older adults metabolize benzodiazepines more slowly, and the cognitive impairment, fall risk, hip fracture risk, and risk of delirium are substantially higher than in younger adults. The American Geriatrics Society Beers Criteria classify benzodiazepines as medications to avoid in older adults except in narrow clinical situations.
SSRIs are first-line, with specific cautions. SSRIs work in older adults but require attention to several issues. Hyponatremia (low sodium) is more common in older adults on SSRIs, particularly with citalopram and escitalopram, and can be serious. Bleeding risk is mildly increased, particularly when combined with anticoagulants or NSAIDs. QTc prolongation is dose-related, more relevant in older patients with cardiac disease. Most clinicians start at lower doses than in younger adults and titrate slowly.
Buspirone is well-tolerated. Non-sedating, no dependence, minimal interactions. Often a reasonable first or second choice in older adults with generalized anxiety.
mirtazapine has a specific niche. The combination of anxiety, depression, insomnia, and weight loss in an older adult fits mirtazapine well.
hydroxyzine carries anticholinergic risk. The anticholinergic effects of first-generation antihistamines are more impactful in older adults and contribute to cognitive impairment with sustained use. The Beers Criteria recommend caution with hydroxyzine in older adults.
Polypharmacy is a real concern. Older adults are often on multiple medications. Drug-drug interactions, especially through the CYP450 enzymes, deserve attention. A pharmacist review can be useful when starting a new psychiatric medication in someone on a complex regimen.
Therapy considerations
CBT works in older adults and has good evidence for late-life anxiety. Adaptations that often help:
- Slower pace, more session-by-session repetition of concepts
- More present-focused work, less emphasis on changing long-standing personality patterns
- Practical, concrete examples rather than abstract conceptual work
- Attention to sensory and physical accommodations (good lighting, larger fonts on handouts, hearing aid considerations)
- Group formats specifically for older adults, which add a social dimension that often helps
Telehealth has expanded access for older adults who have mobility limitations, transportation barriers, or limited local provider options.
What isn't "normal aging"
Several things often dismissed as part of aging that deserve evaluation:
- Persistent worry that interferes with sleep, social activity, or self-care
- Panic attacks
- New onset social withdrawal
- Sustained low mood
- Significant change in cognitive function
- New thoughts of self-harm or wishing not to wake up
Older adults have the highest suicide rates of any age group in the United States, particularly older white men. Treating depression and anxiety in this population isn't a luxury; it has direct safety implications.
External citations
The American Geriatrics Society Beers Criteria cover medications to use cautiously or avoid in older adults. The NIMH page on older adults and mental health provides a patient-facing overview. The GeriatricCareOnline resources include clinician-facing tools.
For the clinical encyclopedia entry on this condition, see Shrinkopedia →